The White House issued a vote of confidence Tuesday that the COVID-19 vaccines are effective against a new virus variant that has caused concern among health experts.
At issue is the so-called “lambda variant,” which the World Health Organization has called a “variant of interest” because it has mutated in a way that could make it more easily passed among humans and may not be nixed by the “neutralizing antibodies” inside the body that the vaccines produce.
Stay informed.Stay ahead.
Join Washington Examiner for unlimited access to the news, analysis, and commentary that matter most.
See Options
Already a member? Log in
Already a print subscriber? Click here to login/register your account
